- The law that could help fix anesthesia reimbursement issues — and why it’s being ignored
- UW Health inks deal to become Packers’ official healthcare partner
- California hospital CEO steps down
- How CHS, HCA, Tenet, and UHS’ CEO-to-worker pay ratios ranked in 2025
- Texas dentist has license suspended
- RFK Jr. says he’ll reform preventive task force: 4 hearing takeaways
- 10 fastest-growing jobs for new graduates
- Northwestern Medicine posts 4.5% operating margin in Q2
- Rotavirus cases increase across US
- Tenet’s 5 highest-paid execs in 2025
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- Tenet’s CEO-to-worker pay ratio widens in 2025
- Wyoming hospital CEO retires
- Stereotaxis to acquire cardiovascular robotics company for $45M
- Meritus Health adds Dr. Christine Lewis
- What’s the deal with insurer mental health parity violations?
- NYU Langone Health opens 12K-square-foot ambulatory location
- 10 anesthesia leadership appointments from Q1
- What could improve physician market competition
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- How ESOPs can help retiring physicians cash out
- Specialty1 Partners’ growth in 2026: 5 updates
- UnityPoint Health to transition dental services to FQHC
- The ownership opportunity ASCs are leaving behind
- New York hospital taps ambulatory operations leader
- 10 trends in behavioral health usage: Report
- How hospitals are winning — and losing — the ASC moment
- 4 DSOs adding new technology
- Aspen Dental opens Michigan office
- Studies reaffirm fluoride safety, benefits: 10 things to know
- New Oklahoma law closes dental insurer price fixing loophole
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- Kentucky approves changes to Dental Practice Act
- Former Utah dentist accused of practicing dentistry without a license
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- EPA Delays Decisions on 'Forever Chemicals'
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- ‘Mini specialists’: 5 models reshaping behavioral health in primary care
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- Progyny unveils new fertility benefit option for small, mid-size employers
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Chicago hospital expands outpatient, walk-in mental health services
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Bill would force payers to apply DTC drug purchases to patient deductibles
- 43 states have mental health insurance disparities: 4 trends
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- The new playbook for clinician well-being
- Listen to the Latest ‘KFF Health News Minute’
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- Anthem, Mount Sinai reach contract agreement, restore in-network coverage
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Stanford Health Care, Alameda Health System partner to support St. Rose Hospital
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Los estados se enfrentan a otro reto con las nuevas reglas laborales de Medicaid: la falta de personal
- States Change Custody Laws To Keep Children of Detained Immigrants Out of Foster Care
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- New Mental Health Parity Index highlights where disparities persist
- Wavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platform
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
- Statement Regarding Staff No-Action Letter to Bank of England
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
The National Institutes of Health (NIH) awards research grants to universities and institutes amounting to about $ 35 billion every year. This $ 35 billion number amounts to $ 26 billion for actual research and $ 9 billion for “indirect costs,” defined as “facilities” and “administration.” Universities, notably the University of Michigan, have ratcheted up these indirect and administration premia to boost federal research contract profits into the stratosphere. Only Uncle Sucker has been paying outrageous junk fees which often exceed 50% of nominal contract value.
No more. The NIH Office of The Director just issued NOT-OD-25-068 which caps these ups and adds at 15%. This is more in line with private foundation research grants, many of which allow no indirect cost billings. Needless to say, universities are howling:
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-068.html
Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost RatesNotice Number:NOT-OD-25-068Release Date:February 7, 2025
Issued By:
Office of The Director, National Institutes of Health (OD)
Purpose
The National Institutes of Health (NIH) awards a large number of grants providing substantial federal funding for research purposes. These grants include significant payments for “indirect costs,” defined as “facilities” and “administration.” 45 CFR 75.414(a). The “facilities” category is “defined as depreciation on buildings, equipment and capital improvements, interest on debt associated with certain buildings, equipment and capital improvements, and operations and maintenance expenses.” Id. And the “administration” category is defined as “general administration and general expenses such as the director’s office, accounting, personnel, and all other types of expenditures not listed specifically under one of the subcategories of ‘Facilities”’ (including cross allocations from other pools, where applicable). Id.
In issuing grants, NIH generally uses the indirect cost rate negotiated by an “agency with cognizance for F&A/indirect cost rate (and other special rate) negotiation.” Grants Policy Statement at IIA-68; see 45 C.F.R. 75.414(c)(1). NIH may, however, use “a rate different from the negotiated rate for either a class of Federal awards or a single Federal award.” 45 C.F.R. 75.414(c)(1). NIH may deviate from the negotiated rate both for future grant awards and, in the case of grants to institutions of higher education (“IHEs”), for existing grant awards. See 45 CFR Appendix III to Part 75, § C.7.a; see 45 C.F.R. 75.414(c)(1).
In deviating from the negotiated indirect cost rate, NIH must “implement, and make publicly available, the policies, procedures, and general decision-making criteria that their programs will follow to seek and justify deviations from negotiated rates.” 45 C.F.R § 75.414(c)(3).
In accordance with 45 CFR 75 and its accompanying appendices, this Guidance implements and makes publicly available NIH’s updated policy deviating from the negotiated indirect cost rate for new grant awards and existing grant awards, effective as of the date of this Guidance’s issuance. Pursuant to this Supplemental Guidance, there will be a standard indirect rate of 15% across all NIH grants for indirect costs in lieu of a separately negotiated rate for indirect costs in every grant.
Providing Indirect Cost Rates that Comport with Market Rates
NIH’s mission is to “seek fundamental knowledge about the nature and behavior of living systems” in order to enhance health, lengthen life, and reduce illness and disability. In furtherance of this mission, NIH spent more than $35 Billion in Fiscal Year 2023 on almost 50,000 competitive grants to more than 300,000 researchers at more than 2,500 universities, medical schools, and other research institutions across all 50 states and the District of Columbia.[1] Of this funding, approximately $26 billion went to direct costs for research, while $9 billion was allocated to overhead through NIH’s indirect cost rate.
Although cognizant that grant recipients, particularly “new or inexperienced organizations,” use grant funds to cover indirect costs like overhead, see 89 FR 30046–30093, NIH is obligated to carefully steward grant awards to ensure taxpayer dollars are used in ways that benefit the American people and improve their quality of life. Indirect costs are, by their very nature, “not readily assignable to the cost objectives specifically benefitted” and are therefore difficult for NIH to oversee. See Grants Policy Statement at I-20. Yet the average indirect cost rate reported by NIH has averaged between 27% and 28% over time.[2] And many organizations are much higher—charging indirect rates of over 50% and in some cases over 60%.
Most private foundations that fund research provide substantially lower indirect costs than the federal government, and universities readily accept grants from these foundations. For example, a recent study found that the most common rate of indirect rate reimbursement by foundations was 0%, meaning many foundations do not fund indirect costs whatsoever. In addition, many of the nation’s largest funders of research—such as the Bill and Melinda Gates Foundation—have a maximum indirect rate of 15%. And in the case of the Gates Foundation, the maximum indirect costs rate is 10% for institutions of higher education.
A sample list of foundations that provide indirect cost funding and their respective maximum indirect rate is below:[3]
Maximum Indirect Cost Rate Organizations
10%
- Gates Foundation (for institutions of higher education)
- Smith Richardson Foundation
12%
- Gordon and Betty Moore Foundation
- Robert Wood Johnson Foundation
15%
- Carnegie Corporation of New York
- Chan Zuckerberg Initiative
- John Templeton Foundation
- Packard Foundation
- Rockefeller Foundation (for institutions of higher education)
Indeed, one recent analysis examined what level of indirect expenses research institutions were willing to accept from funders of research. Of 72 universities in the sample, 67 universities were willing to accept research grants that had 0% indirect cost coverage. One university (Harvard University) required 15% indirect cost coverage, while a second (California Institute of Technology) required 20% indirect cost coverage. Only three universities in the sample refused to accept indirect cost rates lower than their federal indirect rate. These universities were the Massachusetts Institute of Technology, the University of Michigan, and the University of Alabama at Birmingham.
The United States should have the best medical research in the world. It is accordingly vital to ensure that as many funds as possible go towards direct scientific research costs rather than administrative overhead. NIH is accordingly imposing a standard indirect cost rate on all grants of 15% pursuant to its 45 C.F.R. 75.414(c) authority. We note in doing so that this rate is 50% higher than the 10% de minimis indirect cost rate provided in 45 C.F.R. 75.414(f) for NIH grants. We have elected to impose a higher standard indirect cost rate to reflect, among other things, both (1) the private sector indirect cost rates noted above, and (2) the de minimis cost rate of 15% in 2 C.F.R. 200.414(f) used for IHEs and nonprofits receiving grants from other agencies.
NIH Implementation
For any new grant issued, and for all existing grants to IHEs retroactive to the date of issuance of this Supplemental Guidance, award recipients are subject to a 15 percent indirect cost rate. This rate will allow grant recipients a reasonable and realistic recovery of indirect costs while helping NIH ensure that grant funds are, to the maximum extent possible, spent on furthering its mission. This policy shall be applied to all current grants for go forward expenses from February 10, 2025 forward as well as for all new grants issued. We will not be applying this cap retroactively back to the initial date of issuance of current grants to IHEs, although we believe we would have the authority to do so under 45 CFR 75.414(c).
[1] NIH, Budget (Oct. 3, 2024), https://www.nih.gov/ABOUT-NIH/WHAT-WE-DO/BUDGET .
[2] NIH, Fiscal Year 2021 Overview Supplementary Tables at 87, https://officeofbudget.od.nih.gov/pdfs/FY21/br/5-SupplementaryTables.pdf .
[3] See Bill & Melinda Gates Found., Indirect Cost Policy (Feb. 2017), https://docs.gatesfoundation.org/Documents/Indirect_Cost_Policy.pdf ; Smith Richardson Found., Strategy and Policy Fellows Program, https://www.srf.org/wp-content/uploads/2014/04/2021-SPFP-Application-Requirements-and-Proposal-Template.pdf ; Gordon & Betty Moore Found., Moore Inventor Fellows: 2024-2025 FAQ, https://www.moore.org/docs/default-source/moore-inventor-fellows/moore-inventor-fellows-faq.pdf ; Robert Wood Johnson Found., Policies for Action:Grants FAQs, https://anr.rwjf.org/templates/external/P4A_FAQS.pdf; Carnegie Corp. of New York, Grantee FAQs, https://www.carnegie.org/grants/grantee-faqs/#:~:text=What%20is%20your%20indirect%20cost,think%20tanks%2C%20and%20government%20entities; Chan Zuckerberg Initiative, Application Instructions, https://chanzuckerberg.com/wp-content/uploads/2020/06/CZI_Imaging_Scientists_2_Detailed_Instructions.pdf; John Templeton Found., Grant FAQ, https://www.templeton.org/grants/grant-faq;The Packard Found., Fostering Equitable Grantmaking through Indirect Cost Coverage, https://www.packard.org/insights/perspective/fostering-equitable-grantmaking-through-indirect-cost-coverage/ ; The Rockefeller Found., Guidance: Preparing a Project Grant Budget for the Rockefeller Foundation, https://www.rockefellerfoundation.org/wp-content/uploads/2024/06/The-Rockefeller-Foundation-Project-Budget-Guidance-v2024.pdf.
Please direct all inquiries to:
NIH Office of Policy for Extramural Research Administration (OPERA)
Division of Grants Policy
A commentary, from Byron York:
https://www.washingtonexaminer.com/opinion/columnists/3315099/after-nih-move-doge-hysteria-spreads/
After NIH move, DOGE hysteria spreads
By Byron York - February 8, 2025AFTER NIH MOVE, DOGE HYSTERIA SPREADS. There was an alarmist report in the Washington Post over the weekend about the Trump administration and the National Institutes of Health. Beneath the headline, “NIH cuts billions of dollars in biomedical funding, effectively immediately,” the paper cited various sources who said a new way of calculating medical grants, imposed by the Trump administration, would be a “devastating” move that would “imperil … universities and medical centers,” “cripple lifesaving research and innovation,” result in “higher degrees of disease and death in the country,” and “imperil clinical research,” for which Americans would “pay the price with their lives.”
Wow. Here is the issue: When a university or research institution receives a grant from NIH, it charges the government for “indirect costs,” that is, for administrative and overhead costs. The amount charged can vary, but it’s a lot of money. “The average indirect cost rate reported by NIH has averaged between 27 percent and 28 percent over time,” NIH wrote in a statement announcing the new policy. “And many organizations are much higher — charging indirect rates of over 50 percent and in some cases over 60 percent.”
In fiscal 2023, NIH gave out $35 billion in grants. Of that, NIH said, $26 billion went to direct costs for research, while $9 billion went to indirect costs to pay for administration and overhead.
NIH noted that when research institutions receive grants from private foundations, the private foundations don’t pay nearly as much for indirect costs as NIH does. “A recent study found that the most common rate of indirect rate reimbursement by foundations was 0 percent, meaning many foundations do not fund indirect costs whatsoever,” NIH wrote. “In addition, many of the nation’s largest funders of research — such as the Bill and Melinda Gates Foundation — have a maximum indirect rate of 15 percent. And in the case of the Gates Foundation, the maximum indirect costs rate is 10 percent for institutions of higher education.”
NIH also included the maximum indirect costs payment rate for other foundations. The Chan Zuckerberg Initiative is capped at 15%, as is the John Templeton Foundation and the Carnegie Corporation of New York. The Robert Wood Johnson Foundation is capped at 12%, and the Smith Richardson Foundation is capped at 10%.
So this is what the Trump administration did. It announced that NIH will now cap the rate of indirect costs at 15%. That way, the thinking goes, NIH will be more in line with private foundations and will be able to spend more on research and less on administration and overhead. Under the new policy, of the $35 billion spent on grants last year, about $5 billion would go to administration and overhead, instead of the $9 billion that was actually paid in fiscal 2023. The savings would be $4 billion.
It seemed reasonable, but the media reaction approached five alarms. In addition to the Washington Post, the New York Times headline was “Trump Administration Cuts Put Medical Progress at Risk, Researchers Say.” CNN’s headline was “Researchers decry ‘disastrously bad idea’ as NIH slashes payments for research infrastructure.” Not to be outdone, the Huffington Post went with “TRUMP SLEDGEHAMMERS NIH FUNDING; ‘CATASTROPHIC’ HIT TO SCIENCE.”
Democrats in Washington were happy to amplify the point. The new NIH policy “will mean shuttering labs across the country, layoffs in red and blue states, and derailing lifesaving research on everything from cancer to opioid addiction,” Sen. Patty Murray (D-WA) said. Rep. Jamie Raskin (D-MD) called the new policy “another deep wound inflicted against American medicine, science and health by Musk’s juvenile night crew of data thieves following the Project 2025 playbook.”
As Raskin indicated, for Democrats the chief villain in the narrative was, of course, Elon Musk of the Trump-created Department of Government Efficiency, and also the Heritage Foundation’s Project 2025. Musk had called the old, high indirect costs payments a “ripoff.” Last year, Project 2025 recommended that “Congress should cap the indirect cost rate paid to universities so that it does not exceed the lowest rate a university accepts from a private organization to fund research efforts. This market-based reform would help reduce federal taxpayer subsidization of leftist agendas.”
Meanwhile, knowledgeable Republicans were appalled — not at the new policy but at the media/Democratic reaction. “As a physician who has conducted NIH-funded research, I understand how important research funding is,” said Rep. Andy Harris (R-MD), a Johns Hopkins-trained anesthesiologist, in a statement. “But for years, the American taxpayer has paid inflated 50-60 percent ‘indirect costs’ for research in universities while nonprofits, private companies, and foundations only pay 15 percent or less. The NIH’s new indirect cost rate of 15 percent is in line with what research institutions receive from private foundations, and could actually allow more NIH funding to go directly to critical scientific research, instead of funding bloated university bureaucracies, including DEI offices.” The Washington Post article, Harris added, was “grossly misleading.”
All of that came within 24 hours of the announcement of the new policy. It’s not yet clear whether the NIH matter will reach USAID-levels of intensity among Democrats and the media. But it’s off to a strong start.
I am so old I can remember when Democrats and their bureaucrats were totally opposed to "junk fees".
Biden Judge Angel Kelley issued a temporary restraining order today which blocks the National Institute of Health from taking any steps to implement or enforce their rate change notice. Democratic Attorneys General of 22 states filed a lawsuit to block the order on Sunday:
https://thehill.com/policy/healthcare/5137047-federal-judge-restrains-nih-research/
Federal judge grants restraining order on NIH funding cuts
By Joseph Choi - February 10, 2025A federal judge in Massachusetts has granted a restraining order against the National Institutes of Health (NIH) and its recent research funding cut after 22 states filed a lawsuit to block the order.
U.S. District Court Judge Angel Kelley, nominated by former President Biden, granted a request for a temporary restraining order issued Friday on NIH’s Rate Change Notice, which cut indirect cost rates to a standard rate of 15 percent. This funding went toward administrative and facility costs of conducting research.
On Monday, the attorneys general for 22 states filed a lawsuit to block the order, with Kelley’s order coming less than a day after it was filed.
“Defendants and their officers, employees, servants, agents, appointees, and successors are hereby enjoined from taking any steps to implement, apply, or enforce the Rate Change Notice (NOT-OD-25- 068) within Plaintiff States until further order is issued by this Court,” Kelley’s order stated.
The judge gave NIH until Friday to file an opposition to the motion. The Hill has reached out to NIH for comment, though federal health agencies typically do not comment on pending litigation.
“The effects of the Rate Change Notice will be immediate and devastating,” the attorneys general warned in their suit.
“Medical schools, universities, research institutions, and other grant recipients across the country have already budgeted for (and incurred obligations based on) the specific indirect cost rates that had been negotiated and formalized with the federal government through the designated statutory and regulatory legal process,” they added.
“This agency action will result in layoffs, suspension of clinical trials, disruption of ongoing research programs, and laboratory closures.”
Republican Sens. Susan Collins (Maine) and Katie Britt (Ala.) expressed concern over the funding cuts on Monday, with Collins saying she opposed the “poorly conceived directive.”
Britt said in an interview that the funding cuts should be carried out with a targeted approach in order to “not hinder lifesaving, groundbreaking research at high-achieving institutions like those in Alabama.”
Collins on Monday told CNN’s Manu Raju that she would vote for Robert F. Kennedy Jr. to be Health and Human Services secretary after he told her that he would “reexamine” the funding cuts if confirmed.
Democrats will never allow researchers and administrators to miss any payments on their 7 Series BMWs. 😎
Our lying Attorney General participated in the lawsuit against NIH. The NIH rate notice will increase funds that actually go to medical research and reduce funds siphoned off to buy BMW 7 Series luxury cars:
AG Nessel Sues Trump Administration for Defunding Medical and Public Health Innovation Research
February 10, 2025
LANSING – Michigan Attorney General Dana Nessel co-led 22 other attorneys general in today suing the Trump Administration, the Department of Health and Human Services, and the National Institutes of Health (NIH) for unlawfully cutting funds that support cutting-edge medical and public health research at universities and research institutions across the country.The coalition is challenging the Trump Administration’s attempt to unilaterally cut “indirect cost” reimbursements at every research institution throughout the country. These reimbursements cover expenses to facilitate biomedical research, like lab, faculty, infrastructure, and utility costs. Without them, the lifesaving and life-changing medical research in which the United States has long been a leader, could be compromised.
Indirect cost reimbursements are based on each institution’s unique needs, negotiated with the federal government through a carefully regulated process, and then memorialized in an executed agreement. The Trump Administration purports to toss those agreements aside, putting public health and medical advancements at risk. The coalition’s lawsuit seeks to prevent that reckless and illegal conduct.
“This funding supports life saving research,” said Nessel. “These dangerous proposed cuts are indiscriminate and without purpose. They will cost jobs here in Michigan and will hamper tens of thousands of research projects – many of which are currently underway and focus on improving health outcomes and preventing death. I’m proud to lead this effort to restore this essential funding.”
On Friday, February 7, the NIH announced it would abruptly slash indirect cost rates to an across-the-board 15% rate, which is significantly less than the cost required to perform cutting edge medical research. The NIH purported to make this cut effective the very next business day, Monday, February 10, giving universities and institutions no time to plan for the enormous budget gaps they are now facing. Without immediate relief, this action could result in the suspension of lifesaving and life-extending clinical trials, disruption of research programs, layoffs, and laboratory closures.
The coalition argues that this action violates the Administrative Procedure Act, including a directive Congress passed during President Trump’s first term to fend off his earlier proposal to drastically cut research reimbursements. That statutory language, still in effect, prohibits the NIH from requiring categorial and indiscriminate changes to indirect cost reimbursements. The coalition is seeking a court order barring the Trump Administration and NIH from implementing the action.
The NIH is the primary source of federal funding for medical research in the United States. Medical research funding by NIH grants have led to innumerable scientific breakthroughs, including the discovery of treatment for cancers of all types, the first sequencing of DNA and the development of the MRI. Additionally, dozens of NIH-supported scientists have earned Nobel Prizes for their groundbreaking scientific work.
Most NIH-funding research occurs outside of federal government institutions such as both public and private universities and colleges. In Michigan, this includes over $200 million in funding cuts that support research projects at the University of Michigan, Michigan State University and Wayne State University.
This lawsuit is being co-led by the attorneys general of Massachusetts, Illinois, and Michigan. Joining this coalition are the attorneys general of Arizona, California, Connecticut, Colorado, Delaware, Hawaii, Maine, Maryland, Minnesota, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Rhode Island, Vermont, Washington and Wisconsin.
The lawsuit was filed today in U.S. District Court for Massachusetts and can be found here.
Some of issues behind NIH's NOT-OD-25-068 which the media are not disclosing:
https://www.aei.org/op-eds/trumps-nih-is-right-about-bloated-research-grants/
Trump’s NIH Is Right about Bloated Research Grants
By Frederick M. Hess & Jay P. Greene | February 18, 2025The Trump administration wants federal funds for cancer and Alzheimer’s research to go to finding cures rather than subsidizing campus bureaucracies. In response, college leaders have gone to court to stop the National Institutes of Health from reducing taxpayer subsidies for campus slush funds, with matters in the balance due to a federal injunction.
The Trump administration has directed the NIH to slash the amount it pays to universities for “overhead” expenses. Previously, for every dollar universities received for research, the NIH gave them an additional 39 cents for overhead — now, it can’t be more than 15 cents. This means that out of the $35 billion NIH provides in grants, the amount devoted to overhead for things such as administration and facilities would be cut from $9 billion to $4.6 billion. If the injunction currently halting the NIH plan is lifted, the total amount of research funding will remain unchanged, but $4.4 billion will shift from administrators to researchers.
The bellowing from university leaders and hand-wringing headlines might suggest that this effort to combat campus bloat constitutes an all-out assault on science. One of the more telling was the American Prospect article titled “What Trump Could Learn from Hitler on NIH Funding,” which compares Trump to Hitler but laments that he loves science less than Hitler did.
To those more interested in medical advances than media narratives, this fight is bizarre. After all, the NIH isn’t doing anything radical here. The directive the agency issued explained that the move simply sought to ensure that “as many funds as possible go towards direct scientific research costs rather than administrative overhead” — not especially Hitlerian rhetoric, at that.
Why the campus outrage? Well, universities have long treated overhead, also known as “indirect costs,” as a slush fund. Indeed, Columbia University’s “Stand Columbia Society” unapologetically argued that indirect-cost recovery funds “are critical to the financial stability of American universities.” This is because, you see, “While [these funds] are officially earmarked for ‘overhead,’ institutions have considerable discretion in their use. In practice, because money is fungible, many universities use ICR funds to free up other funds to support areas that do not cover their own costs, effectively cross-subsidizing diverse academic programs.”
Such uses are a flagrant violation of federal law. Indeed, the NIH explains that “indirect costs” are to be used specifically for “facilities” or “administration.” The “facilities” category contains expenses such as “depreciation on buildings,” “equipment and capital improvements,” and “operations and maintenance.” Administration means “expenses such as the director’s office, accounting, [and] personnel.” None of this grants universities a free hand to cross-subsidize gender studies, underwrite expansive employee benefits, or fund doctoral programs writ large.
After World War II, the United States deliberately made higher education a pillar of the nation’s approach to research and development. Uncle Sam spends tens of billions of dollars annually to support research at higher-education institutions. The American Association for the Advancement of Science has previously calculated that federal dollars account for roughly 60% of all university-based R&D funding.
In the early decades of the Cold War, universities needed to charge overhead to build out the facilities and support staff that could shoulder the new emphasis on research. Over the decades, that investment should have produced an installed base — one that becomes cheaper to maintain after initial outlays have been made. The exact opposite has happened: As federal spending on university research has risen over the decades, universities have dramatically increased their overhead rates. Meanwhile, the institutions that receive the most federal funding actually charge higher overhead rates than do institutions with fewer grants. Overhead rates are being manipulated by deep-pocketed research universities to extract even more in subsidies from taxpayers.
Prior to the NIH directive, universities had no incentive to lower their administrative costs. Instead, they devised new ways to shift expenses—often unrelated to research — into the “overhead” category. If the Trump administration prevails in court, universities will no longer be able to rely on such tactics. This will force universities to pare down cross-subsidies for doctoral students in the humanities and campus bureaucrats. It will also force them to itemize more of their expenses and ensure that research funds actually fund activities directly related to research. And it will ensure that they are not asking federal taxpayers to pay a second time for infrastructure that donors or state legislatures have already funded.
University leaders say this policy will force them to shutter important research projects. They’re bluffing. Universities were long able to produce research at much lower rates of overhead. Research institutions have a mission to conduct this research, and many have accumulated massive endowments based on that work, and with the understanding that donors want to help it continue. Researchers should be grateful that taxpayers are willing to provide extraordinary resources for research. This largesse should not be mistaken for an entitlement.
Threatening they’ll stop trying to cure cancer if taxpayers reduce subsidies for administrative bloat is no way for unpopular institutions to regain public trust. Here’s hoping they find a way to do better.
NPR interviews Dr. Donald Milton of the University of Maryland, who charges NIH 56% overhead on his research contracts:
https://www.npr.org/2025/02/24/nx-s1-5307157/trump-nih-funding-cut-medical-research
Medical research labs brace for possible funding cuts that could disrupt their work
By Rob Stein - February 24, 2025A Trump administration plan to change how the National Institutes of Health pays for medical research at universities and other institutions has sent shock waves through labs around the country.
Dr. Donald Milton's lab at the University of Maryland, which studies how respiratory viruses spread, faces a threat to its funding and staffing if the new policy goes through.
The centerpiece of his lab is a contraption inside a booth with plastic windows: A giant silver cone that resembles the horn of an old-fashioned gramophone is hooked up to a tangle of wires, tubes and cables.
Funding is stalled for National Institutes of Health research grants.
"We have people come in who have flu or other respiratory infections. The person sits with their face in the cone and the air around them is drawn into the cone," says Milton, a professor of environmental health at the university's School of Public Health in College Park, Md.
The device is one way that Milton and his colleagues study how respiratory viruses like the flu and COVID-19 spread from one person to another.
"That's a big important question because how you stop transmission depends on how that's happening," he says.
But Milton says his work is threatened by the Trump administration proposal to cap indirect costs associated with medical research like his at 15%. His university has been getting about 56%.
"It would be really bad for our work," Milton says. "It would slow us down. It may prevent us from continuing the work in the longer run."
The NIH, which is also reeling from the layoffs of about 1,000 workers in the agency's Bethesda, Md., campus, is the world's largest public funder of biomedical research. The agency spends most of its $48 billion annual budget on research outside the agency, including about $9 billion in indirect costs.
"Since World War II the United States built up the world's most effective and successful research enterprise anywhere in human history," Milton says. "And we did that because the federal government supported the infrastructure that makes research possible. And that's what the indirect costs do. Without that, the whole thing crumbles."
The Trump administration says many institutions could cut bloat or use their endowments to cover those costs. That would allow the NIH to use the $4 billion in savings to pay for even more research outside the elite academic enclaves, the administration says.
Some outside experts agree.
"Rates should be reasonable for universities to cover their overhead and allow more of NIH's budget to be directed towards actual scientific research," says Avik Roy, president of the Foundation for Research on Equal Opportunity, a conservative think tank.
"The majority of people who apply for NIH funding are directed. So by directing more of the funding to scientists we can actually fund more meritorious research," he says.
A federal judge in Boston temporarily blocked the plans to cap NIH funding of indirect costs on Feb. 10, after two lawsuits charged the change would violate federal law. U.S. District Court Judge Angel Kelley is expected to rule any day about whether the cap can go into effect. Lawyers representing the Trump administration, 22 state attorneys general and a coalition of universities, medical school, research hospitals and others presented their arguments for and against the blanket cap during a two-hour hearing on Friday.
If the plan is not stopped, Milton estimates he would lose about $1.1 million of his $3.3 million in NIH funding, forcing him to lay off up to half of his 21-member team.
"That's what has people on edge," Milton says. "It's so hard to know what's going to happen."
The Gesundheit II is just one piece of equipment in just one of the labs that the NIH funds, where Milton and his colleagues conduct their research.
"We are having to replace pieces of our Gesundheit II because it's now going on 20 years old and, you know, stuff wears out," Milton says.
In fact, Milton says about one-third of what he gets from the NIH goes for indirect costs.
"The lights, the maintenance on the machinery, the heat, the air conditioning, the clerks who send out payment bills," he says.
The funding change is just one reason staff at the NIH are on edge. They're also nervous about the confirmation of Robert F. Kennedy Jr., a frequent critic of the agency, to run the Health and Human Services Department, which oversees the NIH. Dr. Jay Bhattacharya, another NIH critic, is President Trump's pick to be the next NIH director.
The NIH is also trying to get the the White House to lift a freeze that's been imposed on the agency on posting any notices in the Federal Register. That freeze is blocking the NIH from convening any new meetings, which is necessary for the agency to move forward with any new grant proposals, halting billions in research funding.
Meantime, research still goes on at Milton's lab. A feverish student arrives to have his blood drawn, nose swabbed, saliva collected and take a turn in the Gesundheit II.
"Are you still doing all right?" one of Milton's assistant asks the student once he's in position. "Could I have you recite the alphabet slowly for me into the cone?"
The goal of this experiment is to help figure out how to protect people against potential threats that could cause the next pandemic, like bird flu.
"Is it airborne? Do masks work? Are there other things that we should be doing, like making sure we have good ventilation and filtration?" Milton says.
These are all questions for which scientists and the medical community would urgently like answers.
U.S. District Judge Angel Kelly made her TRO permanent this week:
Judge blocks White House funding cuts to NIH
By Simon Druker - April 5, 2025April 5 (UPI) -- A federal judge in Massachusetts issued an order this week permanently blocking the White House from limiting funding to the National Institutes of Health.
District Court Judge Angel Kelley delivered the order, after previously issuing a temporary ban prohibiting President Donald Trump's administration from limiting funding to the medical research agency.
U.S. Attorneys asked Kelley to make that decision in a filing, setting the stage for an appeal to a higher court.
The NIH falls under the Department of Health and Human Services and is the primary agency responsible for public health research.
The judge initially issued the temporary order on March 5.
Friday's ruling restores billions in funding for the time being, pending an expected appeal from behalf of the federal government.
"This case presents dispositive legal issues that Defendants will address on appeal to the First Circuit, and entering judgment would serve judicial efficiency and avoid the unnecessary expenditure of party resources," U.S. Attorney Leah Foley and Deputy Associate Attorney General Brian Lea wrote in the government's filing.
The Trump administration in February announced plans to limit how NIH grants to research institutions, including hospitals, can be used for non-scientific aspects of research, such as facility maintenance.
The government argued the move would direct more money to actual scientific research, while hospitals have said it will force them to cover new costs and stifle innovation.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















